Skip to content

Prospective case-control study on neuropsychological testing before and after therapeutic-diagnostic cerebrospinal fluid puncture in patients with idiopathic intracranial hypertension

Prospective case-control study on neuropsychological testing before and after therapeutic-diagnostic cerebrospinal fluid puncture in patients with idiopathic intracranial hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00033278
Enrollment
30
Registered
2024-01-08
Start date
2017-12-06
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G93.2

Interventions

Group 1: Patients with idiopathic intracranial Hypertension after criteria IHS III beta 15 patients with pseudotumor cerebri were examined before and after lumbar drainage using a series of neurocogn

Sponsors

LMU Klinikum
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Diagnosis of idiopathic intracranial hypertension according to the criteria of IHS III beta - Signed informed consent form - Patient age between 18-70 years - Stable medication for at least one week and no intake of centrally acting medication immediately prior to testing

Exclusion criteria

Exclusion criteria: - Concomitant pre-existing illness that could also have an impact on cognitive performance, in particular organically detectable cognitive deficits (e.g. dementia) - Medical contraindications with regard to a cerebrospinal fluid puncture - Severe internal or psychiatric illness - Acute drug or substance abuse - Lack of ability (e.g. impaired vision) and motivation for testing

Design outcomes

Primary

MeasureTime frame
Differences in neurocognitive test batteries between patients and controls

Secondary

MeasureTime frame
Differences in neurocognitive test batteries before and after lumbar puncture of patients

Countries

Germany

Contacts

Public ContactOzan Eren

LMU Klinikum

ozan.eren@med.uni-muenchen.de(089) 9270-2931

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026